Your browser doesn't support javascript.
BSAC Vanguard Series: The future of infection prevention and control: how COVID is already transforming our approach to antimicrobial resistance.
Voss, Andreas.
  • Voss A; Department of Medical Microbiology, Radboud University Medical Centre, Postbus 6500 HB, Nijmegen, The Netherlands.
J Antimicrob Chemother ; 77(3): 545-546, 2022 02 23.
Article in English | MEDLINE | ID: covidwho-1545992
ABSTRACT
COVID -19 stimulated enormous focus on, and change in, infection prevention and control (IPC), not just in the healthcare sector but also among the general public. While global cooperation and guidance are important, there is also an essential role and benefit from national policies that respect local circumstances and cultural differences. Hospitals will have a new role and data sharing and cooperation between areas such as acute and long-term care will be even more important. Further integration of infection control, microbiology and infectious diseases staff in IPC teams is needed. The digital and AI revolutions have roles to play in how and where patients are seen and diagnosed. The built environment may have longer-term influence on changing the behaviour of health professionals than education and training. One constant is the need for highly trained, flexible and motivated staff in these IPC teams.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / COVID-19 Type of study: Randomized controlled trials Limits: Humans Language: English Journal: J Antimicrob Chemother Year: 2022 Document Type: Article Affiliation country: Jac

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cross Infection / COVID-19 Type of study: Randomized controlled trials Limits: Humans Language: English Journal: J Antimicrob Chemother Year: 2022 Document Type: Article Affiliation country: Jac